Deep-Learning Screening for Pulmonary Vein Isolation Non-Responders

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing treatments for advanced cases of atrial fibrillation, such as persistent and long-standing persistent atrial fibrillation, often fail due to the spread of arrhythmogenic triggers and substrates outside the pulmonary veins, making pulmonary vein isolation alone insufficient, and there is a need for personalized treatment strategies.

Innovation Solution

A deep-learning system that uses machine-learning models to predict which atrial fibrillation patients would respond to specific ablation line treatments by analyzing patient demographics, heart component dimensions, and electro-anatomical maps, identifying optimal ablation sites and estimating reconnection probabilities to tailor treatment strategies beyond pulmonary vein isolation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If pulmonary vein isolation alone is used to treat atrial fibrillation, then the treatment procedure is simple and focused, but it fails to effectively treat advanced cases with arrhythmogenic triggers spread outside pulmonary veins

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidtreatment coverage
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The treatment approach is segmented into two distinct strategies: pulmonary vein isolation for paroxysmal atrial fibrillation, and extended ablation lines (roof line, posterior wall line, carina ablation) for persistent and long-standing persistent cases. This segmentation allows the treatment to be tailored to the specific disease stage and anatomical distribution of arrhythmogenic triggers.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The treatment extends from the traditional pulmonary vein isolation (focused on veins) to include ablation of the left atrial posterior wall, roof, and carina regions. This dimensional expansion covers the entire left atrium and addresses arrhythmogenic substrates beyond the pulmonary veins, effectively treating advanced cases with widespread triggers.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Adaptability or versatility

If extended ablation lines are added for persistent atrial fibrillation, then treatment coverage is improved, but the complexity of the procedure increases

Engineering Contradiction:
Improvetreatment coverageVSAvoidprocedure complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The treatment plan is made dynamic and adaptive based on the patient's specific condition. The system selects from multiple pre-defined ablation line templates (roof line, posterior wall line, carina ablation) depending on the detected arrhythmogenic triggers and disease severity, allowing the procedure complexity to match the actual treatment needs rather than applying a fixed complex protocol to all patients.

Inventive Principle:
Principle #15Dynamics

3Ease of operation

If standardized treatment protocols are used for all atrial fibrillation patients, then the treatment process is simple to implement, but it cannot provide personalized care for different disease stages

Engineering Contradiction:
Improvetreatment implementationVSAvoidpersonalized treatment
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The treatment protocol applies different ablation strategies to different anatomical regions and disease stages. Paroxysmal AF patients receive pulmonary vein isolation, while persistent AF patients receive additional roof line and posterior wall ablation. This local quality approach ensures each patient receives the appropriate level of treatment complexity matched to their specific condition.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20250232863A1Methods and systems using deep-learning for identifying pulmonary vein isolation non-responders
Publication Date: 2025.07.17 BIOSENSE WEBSTER (ISRAEL) LTD
  • US20250232863A1 patent drawing
  • US20250232863A1 patent drawing
  • US20250232863A1 patent drawing

AI summary

A system trains a set of machine-learning models to predict which atrial fibrillation patients would respond to which treatments using ablation lines. The models identify an ablation line treatment for a patient based on atrial fibrillation-related features associated with the patient. The models estimate reconnection probabilities for ablation sites associated with at least one ablation line treatment. The models identify patient atrial fibrillation predictors associated with the patient, based on demographics and heart component dimension parameters associated with the patient, and use the at least one ablation line treatment, reconnection probabilities, patient atrial fibrillation predictors, and patient demographics to predict whether the patient would not respond to pulmonary vein isolation only treatment. In response to a prediction that the patient would not respond to pulmonary vein isolation only treatment, the system enables a healthcare provider to provide the at least one ablation line treatment for the patient.